Kalaris Therapeutics Inc$2.48 %
Analyst Rating: Hold
Stock Details
CEO
Andrew Oxtoby
Sector
Healthcare
Industry
Biotechnology
Full Time Employees
14
Address
139 Main Street, Suite 500, Cambridge, MA, 02142
Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.
Top Competitors
Income Statement
Financials
Selected Year
Revenue Estimates
EPS Estimates
Net Income Estimates
Price target for Kalaris Therapeutics Inc $2.48
$0
Min Forecast(+0% )
$249.61
Avg Forecast( +0% )
$325
Max Forecast(+0%)
EPS
Revenue
Institutional Holder
Loading institutional holder data...
Congress Tracker
Showing 0 of 0 results
Insider Trading of Key Employees
Showing 0 of 0 results